Glioma is a metabolically affected disease due to IDH mutation (Dang et al., 2009), and LGG shows the broadest survival correlation with metabolic disorders compared to other tumors (Vander Heiden and DeBerardinis, 2017). This evidence concerns the gene IDH1 and glioma.